Registry of X-linked Adrenoleukodystrophy

Sponsor
Beijing Tiantan Hospital
Study ID
NCT05939232
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - 70 Years
Healthy Volunteers
Accepted

Study Details

This study is a observational study conducted through recruiting X-linked adrenoleukodystrophy (X-ALD) patients, to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients, and to provide a theoretical basis for the treatment and management of X-ALD patients.

Key Dates

First listed
Jul 11, 2023
Start date
Jul 20, 2023
Status verified
Jul 2023
Primary completion
Dec 1, 2028
Completion
Dec 1, 2028

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: X-ALD
    X-linked adrenoleukodystrophy (X-ALD) patients.
  • Arm: Carrier-control (CC)
    Carriers of mutation in gene encoding ATP-binding cassette subfamily D member 1 (ABCD1), who have no X-linked adrenoleukodystrophy and are matched with the X-ALD group according to age, sex and education.

Primary Outcome Measure

Epidemiological characteristics in Chinese X-ALD patients [ Time Frame: 5 years ]

Central Contacts

Related Studies